JP2024521921A5 - - Google Patents
Info
- Publication number
- JP2024521921A5 JP2024521921A5 JP2023574590A JP2023574590A JP2024521921A5 JP 2024521921 A5 JP2024521921 A5 JP 2024521921A5 JP 2023574590 A JP2023574590 A JP 2023574590A JP 2023574590 A JP2023574590 A JP 2023574590A JP 2024521921 A5 JP2024521921 A5 JP 2024521921A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- conjugate
- acceptable salt
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163202273P | 2021-06-03 | 2021-06-03 | |
| US63/202,273 | 2021-06-03 | ||
| US202163282585P | 2021-11-23 | 2021-11-23 | |
| US63/282,585 | 2021-11-23 | ||
| PCT/IB2022/055167 WO2022254376A1 (en) | 2021-06-03 | 2022-06-02 | Neodegrader conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521921A JP2024521921A (ja) | 2024-06-04 |
| JP2024521921A5 true JP2024521921A5 (https=) | 2025-06-11 |
Family
ID=84323936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574590A Pending JP2024521921A (ja) | 2021-06-03 | 2022-06-02 | ネオデグラダーコンジュゲート |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20250090681A1 (https=) |
| EP (1) | EP4346909A4 (https=) |
| JP (1) | JP2024521921A (https=) |
| KR (1) | KR20240040067A (https=) |
| CN (2) | CN119499399A (https=) |
| AU (1) | AU2022287316A1 (https=) |
| CA (1) | CA3222182A1 (https=) |
| CL (2) | CL2023003604A1 (https=) |
| CO (1) | CO2023016711A2 (https=) |
| IL (1) | IL308811A (https=) |
| MX (1) | MX2023014284A (https=) |
| PE (1) | PE20250115A1 (https=) |
| TW (1) | TW202313124A (https=) |
| WO (1) | WO2022254376A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3058360A1 (en) | 2017-03-29 | 2018-10-04 | Legochem Biosciences, Inc. | Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same |
| EP4667463A1 (en) * | 2023-02-15 | 2025-12-24 | CSPC Megalith Biopharmaceutical Co., Ltd. | Domide molecular glue derivative and use thereof |
| JP2026510495A (ja) * | 2023-03-10 | 2026-04-07 | リガケム バイオサイエンシズ， インク． | ヒトｌ１ｃａｍに対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
| WO2024222841A1 (zh) | 2023-04-27 | 2024-10-31 | 石药集团巨石生物制药有限公司 | 一种抗体药物偶联物 |
| WO2025168071A1 (zh) * | 2024-02-08 | 2025-08-14 | 映恩生物制药（苏州）有限公司 | 一种含氮杂环化合物、其偶联物及其制备方法和用途 |
| WO2025259615A1 (en) * | 2024-06-11 | 2025-12-18 | Triana Biomedicines, Inc. | Modulators of cdk2 and uses thereof |
| WO2026007898A1 (zh) * | 2024-07-01 | 2026-01-08 | 上海海雁医药科技有限公司 | 含苯乙氧基亚烷基胺结构的异吲哚啉化合物、其药物组合物及应用 |
| WO2026041050A1 (zh) * | 2024-08-20 | 2026-02-26 | 海思科医药集团股份有限公司 | 一种配体-蛋白降解剂偶联物及其在医药上的应用 |
| WO2026069278A1 (en) * | 2024-09-30 | 2026-04-02 | Orum Therapeutics, Inc. | Anti-cd123 antibodies and neodegrader conjugates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2358697E (pt) * | 2008-10-29 | 2016-02-03 | Celgene Corp | Compostos de isoindolina para utilização no tratamento do cancro |
| BR112022019532A2 (pt) * | 2020-03-31 | 2022-12-06 | Orum Therapeutics Inc | Conjugados de neodegrader |
-
2022
- 2022-06-02 IL IL308811A patent/IL308811A/en unknown
- 2022-06-02 CN CN202411248905.0A patent/CN119499399A/zh active Pending
- 2022-06-02 CA CA3222182A patent/CA3222182A1/en active Pending
- 2022-06-02 KR KR1020247000099A patent/KR20240040067A/ko active Pending
- 2022-06-02 PE PE2023003197A patent/PE20250115A1/es unknown
- 2022-06-02 JP JP2023574590A patent/JP2024521921A/ja active Pending
- 2022-06-02 AU AU2022287316A patent/AU2022287316A1/en active Pending
- 2022-06-02 EP EP22815473.8A patent/EP4346909A4/en active Pending
- 2022-06-02 TW TW111120734A patent/TW202313124A/zh unknown
- 2022-06-02 CN CN202280052606.2A patent/CN118055779A/zh active Pending
- 2022-06-02 US US18/566,822 patent/US20250090681A1/en active Pending
- 2022-06-02 MX MX2023014284A patent/MX2023014284A/es unknown
- 2022-06-02 WO PCT/IB2022/055167 patent/WO2022254376A1/en not_active Ceased
-
2023
- 2023-12-01 CO CONC2023/0016711A patent/CO2023016711A2/es unknown
- 2023-12-01 CL CL2023003604A patent/CL2023003604A1/es unknown
-
2026
- 2026-02-10 CL CL2026000398A patent/CL2026000398A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024521921A5 (https=) | ||
| JP2024020298A5 (https=) | ||
| JP2022537158A5 (https=) | ||
| IL302078A (en) | Anti-CCR8 monoclonal antibodies and their uses | |
| JP2022093564A5 (https=) | ||
| JP2021524244A5 (https=) | ||
| JP2023515941A5 (https=) | ||
| JP2023547323A5 (https=) | ||
| IL276830B1 (en) | Anti-claudin 18.2 antibodies and their uses | |
| JP2020509027A5 (https=) | ||
| JP2021514664A5 (https=) | ||
| JPWO2020122034A5 (https=) | ||
| JP2019536740A5 (https=) | ||
| JP2021527640A5 (https=) | ||
| JP2023539715A5 (https=) | ||
| JP2023081303A5 (https=) | ||
| JP2018108081A5 (https=) | ||
| JP2019532056A5 (https=) | ||
| JP2024546497A5 (https=) | ||
| JP2010535713A5 (https=) | ||
| JP2017506630A5 (https=) | ||
| JP2024531409A5 (https=) | ||
| JP2020500834A5 (https=) | ||
| JP2009545325A5 (https=) | ||
| JP2004529963A5 (https=) |